Subtopic Deep Dive

Glutamine Transport and Metabolism
Research Guide

What is Glutamine Transport and Metabolism?

Glutamine transport and metabolism encompasses the uptake of glutamine via transporters like SLC38A2 and SLC1A5, followed by its conversion to glutamate and α-ketoglutarate through glutaminase-driven glutaminolysis, fueling nucleotide synthesis, redox balance, and mTOR signaling in proliferating cells.

Key transporters SLC38A2 (SNAT2) and SLC1A5 (ASCT2) mediate sodium-coupled glutamine influx, essential for cancer cell proliferation (Nicklin et al., 2009, 1715 citations). Glutaminolysis supports biosynthetic demands and redox homeostasis via glutathione production (Hensley et al., 2013). Dysregulation occurs in pancreatic cancer through KRAS-dependent pathways (Son et al., 2013, 1912 citations). Over 10,000 papers link glutamine metabolism to metabolic diseases.

Curated Papers

Key Challenges

Why It Matters

Glutamine addiction in cancer cells creates vulnerabilities targeted by transporter inhibitors, as SLC1A5 blockade reduces tumor growth (Nicklin et al., 2009). In pancreatic cancer, KRAS drives glutamine uptake for TCA cycle anaplerosis and nucleotide synthesis (Son et al., 2013). Glutamine supports redox balance via NADPH production, critical in fibrosis and immune evasion (Hensley et al., 2013; Yoo et al., 2020). Pharmacological modulation of glutaminolysis shows promise in clinical trials for glutamine-dependent malignancies.

Key Research Challenges

Transporter Specificity

Distinguishing SLC38A2 from SLC1A5 functions remains difficult due to overlapping expression in tumors. Nicklin et al. (2009) showed bidirectional transport regulates mTOR, but selective inhibitors are lacking. Quantitative imaging is needed for precise localization (Lehre et al., 1995).

Glutaminolysis Quantification

Measuring flux through glutaminase in vivo is challenging amid variable isotope labeling. Son et al. (2013) used 13C-tracing in KRAS models, but tissue heterogeneity complicates results. Advanced metabolomics integration is required.

Therapeutic Resistance

Cancer cells adapt to glutamine deprivation via autophagy and alternative fuels (Nicklin et al., 2009). Hensley et al. (2013) highlight signaling feedbacks, demanding combination therapies. Predictive biomarkers for glutamine dependency are undeveloped.

Essential Papers

Arginine metabolism: nitric oxide and beyond

Guoyao Wu, Sidney M. Morris · 1998 · Biochemical Journal · 2.8K citations

Arginine is one of the most versatile amino acids in animal cells, serving as a precursor for the synthesis not only of proteins but also of nitric oxide, urea, polyamines, proline, glutamate, crea...

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway

Jaekyoung Son, Costas A. Lyssiotis, Haoqiang Ying et al. · 2013 · Nature · 1.9K citations

The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver

DH Williamson, P. Kay Lund, HA Krebs · 1967 · Biochemical Journal · 1.9K citations

1. The concentrations of the oxidized and reduced substrates of the lactate-, beta-hydroxybutyrate- and glutamate-dehydrogenase systems were measured in rat livers freeze-clamped as soon as possibl...

Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy

Paul Nicklin, Philip J. Bergman, Bailin Zhang et al. · 2009 · Cell · 1.7K citations

The return of metabolism: biochemistry and physiology of the pentose phosphate pathway

Anna Stincone, Alessandro Prigione, Thorsten Cramer et al. · 2014 · Biological reviews/Biological reviews of the Cambridge Philosophical Society · 1.4K citations

ABSTRACT The pentose phosphate pathway ( PPP ) is a fundamental component of cellular metabolism. The PPP is important to maintain carbon homoeostasis, to provide precursors for nucleotide and amin...

The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation

Andrew P. Halestrap, Nigel T. Price · 1999 · Biochemical Journal · 1.3K citations

Monocarboxylates such as lactate and pyruvate play a central role in cellular metabolism and metabolic communication between tissues. Essential to these roles is their rapid transport across the pl...

Glutamine and cancer: cell biology, physiology, and clinical opportunities

Christopher T. Hensley, Ajla Wasti, Ralph J. DeBerardinis · 2013 · Journal of Clinical Investigation · 1.2K citations

Glutamine is an abundant and versatile nutrient that participates in energy formation, redox homeostasis, macromolecular synthesis, and signaling in cancer cells. These characteristics make glutami...

Reading Guide

Foundational Papers

Start with Nicklin et al. (2009) for transporter-mTOR links (1715 citations), then Son et al. (2013) for cancer glutaminolysis (1912 citations), followed by Wu & Morris (1998) for amino acid context (2775 citations).

Recent Advances

Yoo et al. (2020) on mitochondrial glutamine reliance (910 citations); Hensley et al. (2013) for clinical targeting (1225 citations).

Core Methods

13C-isotopomer tracing (Son et al., 2013); transporter knockdown (Nicklin et al., 2009); redox assays via NAD+/NADH ratios (Williamson et al., 1967); quantitative immunocytochemistry (Lehre et al., 1995).

How PapersFlow Helps You Research Glutamine Transport and Metabolism

Discover & Search

Research Agent uses citationGraph on Nicklin et al. (2009) to map 1,700+ citing papers on SLC38A2/SLC1A5-mTOR links, then exaSearch for 'glutamine transporter inhibitors cancer trials' to uncover 500+ clinical studies. findSimilarPapers expands to Yoo et al. (2020) for mitochondrial perspectives.

Analyze & Verify

Analysis Agent applies readPaperContent to Son et al. (2013) for KRAS-glutamine pathway extraction, then runPythonAnalysis on 13C-tracing data for flux modeling with NumPy/pandas. verifyResponse (CoVe) with GRADE grading scores metabolic claims A-grade if backed by 5+ citations; statistical verification tests transporter expression correlations.

Synthesize & Write

Synthesis Agent detects gaps like missing SLC1A5 structural models, flags contradictions between Nicklin (2009) and Hensley (2013) on mTOR dependency. Writing Agent uses latexEditText for pathway equations, latexSyncCitations to integrate 20 papers, latexCompile for publication-ready reviews, and exportMermaid for glutaminolysis diagrams.

Use Cases

"Model glutamine flux in pancreatic cancer cells using 13C data from Son 2013."

Research Agent → searchPapers('Son 2013 glutamine') → Analysis Agent → readPaperContent → runPythonAnalysis (pandas isotopomer fitting, matplotlib flux plots) → researcher gets quantifiable glutaminolysis rates with error bars.

"Write LaTeX review on SLC1A5 inhibitors with citations."

Synthesis Agent → gap detection → Writing Agent → latexEditText (draft sections) → latexSyncCitations (20 papers) → latexCompile → researcher gets PDF with embedded glutaminolysis figure and bibliography.

"Find code for glutamine transporter simulations."

Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets Python scripts for SLC38A2 kinetic modeling from linked repos.

Automated Workflows

Deep Research workflow scans 50+ papers via citationGraph from Nicklin et al. (2009), producing structured reports on transporter subtypes with GRADE-scored evidence. DeepScan applies 7-step CoVe to Son et al. (2013) tracing data, verifying KRAS dependencies with Python flux analysis. Theorizer generates hypotheses on glutamine-mTOR feedbacks from Hensley et al. (2013) and Yoo et al. (2020).

Try Doxa for Glutamine Transport and Metabolism Research

Frequently Asked Questions

What defines glutamine transport and metabolism?

It covers SLC1A5/SLC38A2-mediated uptake and glutaminolysis to glutamate/α-KG for biosynthesis and signaling (Nicklin et al., 2009).

What are key methods in this field?

13C-glutamine tracing measures flux (Son et al., 2013); siRNA knockdown assesses transporter roles (Nicklin et al., 2009); immunocytochemistry localizes proteins (Lehre et al., 1995).

What are seminal papers?

Nicklin et al. (2009, Cell, 1715 citations) on amino acid transport-mTOR; Son et al. (2013, Nature, 1912 citations) on KRAS-glutamine; Hensley et al. (2013, JCI, 1225 citations) on cancer opportunities.

What open problems exist?

Selective SLC1A5 inhibitors, in vivo flux quantification, and resistance mechanisms to glutaminase blockade remain unsolved (Hensley et al., 2013; Yoo et al., 2020).